In The Media

Oct 5, 2023

Clinical Lab Products: Castle Biosciences’ Gene Expression Profile Test Effectively Predicts Sentinel Lymph Node Positivity

Sep 28, 2023

Pittsburgh Tribune-Review: Cancer Diagnostics Firm Says It's Growing on the North Side

Sep 28, 2023

Nasdaq: Castle Biosciences, Inc. Rings the Nasdaq Stock Market Closing Bell

Sep 13, 2023

LabPulse.com: Castle Biosciences Pittsburgh Lab Receives N.Y. State Permit

Aug 17, 2023

Dermatology Times: 31-Gene Expression Profile Test Accurately Classified Risk of Death From Melanoma

Aug 14, 2023

Clinical Lab Products: New Study Shows Efficacy of Castle Biosciences Barrett’s Esophagus Test

Aug 7, 2023

Cancer Network: 31-GEP Assay May Help to Extend Survival in Cutaneous Melanoma

Aug 1, 2023

The Pathologist: The Power of Gene Expression Profiling

Jul 16, 2023

AZCentral: Arizona Top Workplaces 2023

Jul 14, 2023

Healio Dermatology: 31-GEP Test Lowers Melanoma-Specific Mortality by 29%